Ling Wang Email & Phone Number | As a Clinical Data Scientist at DRT Strategies, I collaborate with clinical reviewers in the Office of New Drugs (OND) within the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA). I provide expert analysis of safety data collected during clinical trials, including adverse events, laboratory abnormalities, and serious safety issues. With more than 10 years of experience in biotechnology and data science, I have developed and applied standard data analysis workflows for complex data from in vitro, in vivo, and human clinical studies. My core competencies include R (expert level) and SAS (intermediate level), longitudinal data analysis, time-to-event analysis, correlation analysis, machine learning, and network analysis. I also have expert knowledge and hands-on experience with CDISC standards, including SDTM and ADaM. My mission is to provide accurate, reliable, and compliant safety data analysis reports that support the FDA's decision-making process and protect public health.

Ling Wang

As a Clinical Data Scientist at DRT Strategies, I collaborate with clinical reviewers in the Office...
United States

*50 free lookup(s) per month.

Ling Wang’s Email lwang18@ncsu.edu

Ling Wang’s Phone Numbers

Get LING’s Phone Number (For Free)

Social Media

Ling Wang’s Location United States

Ling Wang’s Current Industry Drt Strategies

Ling Wang’s Prior Industry The University Of Chicago Pritzker School Of Medicine | North Carolina State University | National Cheng Kung University

Find accurate emails & phone numbers for over 700M professionals.

Clinical Data Scientist

2023-02-01 00:00:00 - Present

Postdoctoral Scholar

2019-09-01 00:00:00 - 2022-08-01 00:00:00

Postdoctoral Researcher

2018-06-01 00:00:00 - 2019-09-01 00:00:00

Research Assistant

2007-08-01 00:00:00 - 2009-12-01 00:00:00

No Skills Available

No Languages Available

Ling Wang is a As a Clinical Data Scientist at DRT Strategies, I collaborate with clinical reviewers in the Office of New Drugs (OND) within the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA). I provide expert analysis of safety data collected during clinical trials, including adverse events, laboratory abnormalities, and serious safety issues. With more than 10 years of experience in biotechnology and data science, I have developed and applied standard data analysis workflows for complex data from in vitro, in vivo, and human clinical studies. My core competencies include R (expert level) and SAS (intermediate level), longitudinal data analysis, time-to-event analysis, correlation analysis, machine learning, and network analysis. I also have expert knowledge and hands-on experience with CDISC standards, including SDTM and ADaM. My mission is to provide accurate, reliable, and compliant safety data analysis reports that support the FDA's decision-making process and protect public health.

Ling Wang has prior
experience in the following industries:
The University Of Chicago Pritzker School Of Medicine | North Carolina State University | National Cheng Kung University

Ling Wang has the following professional experience:
Drt Strategies | The University Of Chicago Pritzker School Of Medicine | North Carolina State University | National Cheng Kung University